📢📢Call for Papers!
#CancerPlus is accepting submissions in #Cancer research. Submit your groundbreaking work today and contribute to advancing the field!
#Cancer#OpenAccess#callforpapers
👉More Details: https://t.co/iUZxohz65J
📚 Review Collection | No. 7
📜Long non-coding RNAs and drug resistance in breast cancer patients: A scoping review
🔗https://t.co/6kNy3vCgPT
Keywords: Breast cancer; Long non-coding RNAs; Drug resistance; Biomarkers; Therapeutics
📚 Review Collection | No. 6
📜From multicellular constraint to unicellular control: Ancient mechanisms of genome reconstruction, repair, and expansion in cancer evolution
🔗https://t.co/KzAAGbWfPt
Keywords: Cancer; Entamoeba; Stemgermline; Committed cancer stem cells
📚 Review Collection | No. 4
📜Cross-border healthcare policies and cancer care: Strategic opportunities for medical tourism in South Asia
🔗https://t.co/Mbd98nqVTF
Keywords: Cross-border healthcare; Cancer care; Medical tourism; South Asia; Health policy Regional cooperation
📚 Review Collection | No. 3
📜Quantitative bibliometric insights into cisplatin resistance in breast cancer (2010–2024): Implications for drug development
🔗https://t.co/1nlOVmjyvF
Keywords: Breast cancer; Bibliometrics; Research trends
📢 Call for Early Career Editorial Board Members
✨ Gain editorial experience
✨ Collaborate with international scholars
✨ Contribute to high-quality scientific publishing
📩 [email protected]
Contact us for more details!
#YouthEditorialBoard#EarlyCareerResearchers
📢 Join Our Editorial Board!
✨ Expand your academic influence
✨ Engage with leading researchers worldwide
✨ Support high-quality scientific publishing
📩 [email protected]
Contact us to learn more about this opportunity!
#EditorialBoard#CallForEditors#CancerResearch
📢 Call for Guest Editors – Special Issues!
Benefits include:
• Expanding your academic network
• Increasing your research visibility
• Leading discussions on cutting-edge topics
📩 Contact us to propose your Special Issue!
#GuestEditor#SpecialIssue#CancerResearch
🔍 Article Highlight | Now Online
CASE REPORT
📃Title: Plummer–Vinson syndrome complicated by Schatzki ring, non-Hodgkin lymphoma, and myeloproliferative disorder: A rare case report from Pakistan
👉Link: https://t.co/pPbZFpAaj7
#nonHodgkinLymphoma#myeloproliferativeDisorder
📢 New Article Highlight
Type: CASE SERIES
📃Title: Severe lactic acidosis in association with CD5+ large B-cell lymphoma
👉Link: https://t.co/rLxGAm4E3d
#lymphoma#LacticAcidosis#LiverBiopsy
📢 New Article Highlight
Type: MINI-REVIEW
📃Title: Artificial intelligence and surgical robotics in the future of head-and-neck cancer care
👉Link: https://t.co/mgQAyVEmar
#ArtificialIntelligence#HeadAndNeckCancer#SurgicalRobots
🔍 Article Highlight
Type: ORIGINAL RESEARCH ARTICLE
👉In silico assessment of cannabinoids and related compounds as multi-target modulators of IL-2, TNF-α, HSP70/HSP90, EGF signaling, and MMP-2/MMP-9 in ovarian cancer
🔗Read https://t.co/gpBDwSJ2h6
#OvarianCancer#Phytocompounds
🔍 Article Highlight | Now Online
Type: ORIGINAL RESEARCH ARTICLE
👉Title: Genetic alterations of APC and MYC in fibroadenoma and invasive ductal adenocarcinoma: Implications for pathogenesis and personalized gene therapy
🔗 Read more: https://t.co/EQwvo6lDXY
#TargetedTherapy
📢 New Article Highlight
Type: ORIGINAL RESEARCH ARTICLE
📃Title: Feasibility and acceptability of HPV DNA self-sampling in a low-resource setting
👉Link: https://t.co/kptTpXOz2M
#HPV#DNA#CancerScreening
🔍 Article Highlight | Now Online
Type: ORIGINAL RESEARCH ARTICLE
📃Title: Expression profile and clinical significance of IL-17B/IL-17RB in laryngeal squamous cell carcinoma
👉Link: https://t.co/52AaUqqbPj
#Laryngealsquamouscellcarcinoma#IL17B#IL17RB
🔍 Article Highlight | Now Online
Type: ORIGINAL RESEARCH ARTICLE
📃Title: Pre-operative prediction of high-risk molecular subtypes of glioma based on multimodal MRI tumor habitat imaging
👉Link: https://t.co/u5XnQXLCpg
#Glioma#Radiomics#MRI
📢 New Article Highlight
Type: PERSPECTIVE ARTICLE
📃Title: Application of CRISPR–Cas9 technology in the treatment of chronic lymphocytic leukemia with TP53 mutations
👉Link: https://t.co/Y5P4n8SAwO
#CRISPRCas9#TP53#chroniclymphocyticleukemia